Pfizer’s Biosimilar Strategy Might Be Working

 
• By Jessica Merrill

Pfizer's biosimilar franchise  is well on its way to becoming a blockbuster business three years after the company launched its first US biosimilar.

The key of success close to open the door.
Has Pfizer found the key to success in biosimilars? • Source: Shutterstock

More from Archive

More from Scrip